# Pauci-Immune Crescentic Glomerulonephritis Associated With Primary Sjögren Syndrome: A Case Report

**Authors:** Fabian M Rivas Vega, María F Mendoza Rodriguez, Jaime Loeza-Suárez

PMC · DOI: 10.7759/cureus.102261 · Cureus · 2026-01-25

## TL;DR

A rare case of kidney disease in a patient with Sjögren syndrome is reported, highlighting the importance of early diagnosis for better treatment outcomes.

## Contribution

This case report presents an atypical renal manifestation of primary Sjögren syndrome in the absence of ANCA antibodies.

## Key findings

- A 30-year-old woman with primary Sjögren syndrome developed pauci-immune crescentic glomerulonephritis.
- Renal biopsy confirmed pauci-immune GN without immune complex deposition or ANCA positivity.
- Treatment with corticosteroids improved renal function, emphasizing the need for prompt diagnosis.

## Abstract

Primary Sjögren syndrome (SS) is a chronic systemic autoimmune disease predominantly characterized by exocrine gland involvement; however, extraglandular manifestations, including renal involvement, may occur and contribute significantly to morbidity. Renal involvement most commonly presents as tubulointerstitial nephritis, while glomerular disease is considerably less frequent. Pauci-immune crescentic glomerulonephritis (GN) is an exceptionally rare renal manifestation of primary SS and is typically associated with antineutrophil cytoplasmic antibody (ANCA)-related vasculitis, although antibody negativity has been described in isolated cases.

We report the case of a 30-year-old female with no significant past medical history who presented with hypertensive crisis and rapidly progressive renal dysfunction. Laboratory evaluation revealed acute kidney injury with significant proteinuria. Further evaluation identified sicca symptoms, positive antinuclear antibodies at high titers, and elevated anti-SS-related antigen A antibodies, with normal complement levels and negative ANCAs. Minor salivary gland biopsy confirmed the diagnosis of primary SS. Renal biopsy demonstrated pauci-immune crescentic GN with advanced chronic changes and absence of immune complex deposition on immunofluorescence. The patient was treated with intravenous pulse corticosteroids, resulting in improvement of renal function. This report highlights a rare and atypical form of renal involvement in primary SS and underscores the importance of considering pauci-immune GN in patients with SS presenting with rapidly progressive renal failure, even in the absence of ANCAs. Early recognition and prompt histopathological diagnosis are essential to guide appropriate immunosuppressive therapy and improve renal outcomes.

## Linked entities

- **Diseases:** Acute kidney injury (MONDO:0002492)

## Full-text entities

- **Genes:** CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, TRIM21 (tripartite motif containing 21) [NCBI Gene 6737] {aka RNF81, RO52, Ro/SSA, SSA, SSA1, TRIM21/Ro52}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, MPO (myeloperoxidase) [NCBI Gene 4353], PRTN3 (proteinase 3) [NCBI Gene 5657] {aka ACPA, AGP7, C-ANCA, CANCA, MBN, MBT}, CD79A (CD79a molecule) [NCBI Gene 973] {aka IGA, IGAlpha, MB-1, MB1}
- **Diseases:** ocular and oral dryness (MESH:D014987), membranous GN (MESH:D015433), glomerular disease (MESH:D007674), systemic vasculitis (MESH:D056647), lymphocytic sialadenitis (MESH:D012793), immune complex (MESH:D007105), Cryoglobulinemic GN (MESH:D005921), rheumatoid arthritis (MESH:D001172), hypertensive (MESH:D006973), acute tubular injury (MESH:D001930), infection (MESH:D007239), monoclonal gammopathy (MESH:D010265), involvement (MESH:C564676), Renal involvement (MESH:C565423), sclerosis (MESH:D012598), Tubulointerstitial nephritis (MESH:D009395), autoimmune disease (MESH:D001327), immune-mediated disorders (MESH:C567355), acute kidney injury (MESH:D058186), autoinflammatory (MESH:D056660), proteinuria (MESH:D011507), acute nephritic syndrome (MESH:D000208), systemic lupus erythematosus (MESH:D008180), arteriopathy (MESH:D020212), glomerular inflammation (MESH:D007249), vasculitis (MESH:D014657), fibrosis (MESH:D005355), hematuria (MESH:D006417), systemic autoimmune disease (MESH:D020274), postinfectious GN (MESH:D016918), xerophthalmia (MESH:D014985), renal failure (MESH:D051437), Primary Sjogren Syndrome (MESH:D012859), ANCA (MESH:D056648), anti-glomerular basement membrane disease (MESH:D019867), atrophy (MESH:D001284), chronic kidney disease (MESH:D051436)
- **Chemicals:** eosin (MESH:D004801), creatinine (MESH:D003404), hematoxylin (MESH:D006416), rituximab (MESH:D000069283), methylprednisolone (MESH:D008775), cyclophosphamide (MESH:D003520)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12931569/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12931569/full.md

## References

20 references — full list in the complete paper: https://tomesphere.com/paper/PMC12931569/full.md

---
Source: https://tomesphere.com/paper/PMC12931569